zolsketil pegylated liposomal
accord healthcare s.l.u. - doxorubicin hydrochloride, liposomal - ovarian neoplasms; sarcoma, kaposi; multiple myeloma - doxorubicin - zolsketil pegylated liposomal is a medicine used to treat the following types of cancer in adults:• breast cancer that has spread to other parts of the body in patients at risk of heart problems. zolsketil pegylated liposomal is used on its own for this disease;• advanced ovarian cancer in women whose previous treatment including a platinum-based cancer medicine has stopped working;• multiple myeloma (a cancer of the white blood cells in the bone marrow), in patients with progressive disease who have received at least one other treatment in the past and have already had, or are unsuitable for, a bone marrow transplantation. zolsketil pegylated liposomal is used in combination with bortezomib (another cancer medicine);• kaposi’s sarcoma in patients with aids who have a very damaged immune system. kaposi’s sarcoma is a cancer that causes abnormal tissue to grow under the skin, on moist body surfaces or on internal organs. zolsketil pegylated liposomal contains the active substance doxorubicin and is a ‘hybrid medicine’. this means that it is similar to a ‘reference medicine’ containing the same active substance called adriamycin. however, in zolsketil pegylated liposomal the active substance is enclosed in tiny fatty spheres called liposomes, whereas this is not the case for adriamycin.
doxorubicin-ebewe 2mg/ml solution for infusion, concentrate for
t.c.christoforou ltd - ΔΟΞΟΡΟΥΒΙΚΊΝΗ - solution for infusion, concentrate for - 2mg/ml - 0023214928 - doxorubicin - 2 mg - doxorubicin
doxorubicin hydrochloride/ebewe 10mg/5ml vial sol.inf
ΦΑΡΜΑΝΕΛ ΦΑΡΜΑΚΕΥΤΙΚΗ Α.Ε. - doxorubicin - ΔΙΑΛΥΜΑ ΓΙΑ ΕΓΧΥΣΗ - 10mg/5ml vial - ΦΑΡΜΑΚΕΥΤΙΚΟ ΠΡΟΪΟΝ
doxorubicin hydrochloride/ebewe 50mg/25ml vial sol.inf
ΦΑΡΜΑΝΕΛ ΦΑΡΜΑΚΕΥΤΙΚΗ Α.Ε. - doxorubicin - ΔΙΑΛΥΜΑ ΓΙΑ ΕΓΧΥΣΗ - 50mg/25ml vial - ΦΑΡΜΑΚΕΥΤΙΚΟ ΠΡΟΪΟΝ
celdoxome pegylated liposomal
yes pharmaceutical development services gmbh - υδροχλωρική δοξορουβικίνη - breast neoplasms; ovarian neoplasms; multiple myeloma; sarcoma, kaposi - Αντινεοπλασματικοί παράγοντες - celdoxome pegylated liposomal is indicated in adults:as monotherapy for patients with metastatic breast cancer, where there is an increased cardiac risk. or treatment of advanced ovarian cancer in women who have failed a first-line platinum-based chemotherapy regimen. in combination with bortezomib for the treatment of progressive multiple myeloma in patients who have received at least one prior therapy and who have already undergone or are unsuitable for bone marrow transplant. for treatment of aids-related kaposi’s sarcoma (ks) in patients with low cd4 counts (< 200 cd4 lymphocytes/mm3) and extensive mucocutaneous or visceral disease. celdoxome pegylated liposomal may be used as first-line systemic chemotherapy, or as second line chemotherapy in aids-ks patients with disease that has progressed with, or in patients intolerant to, prior combination systemic chemotherapy comprising at least two of the following agents: a vinca alkaloid, bleomycin and standard doxorubicin (or other anthracycline).
doxotil inj.sol 10mg/5ml vial
genepharm ae 18 ΧΛΜ. Λ. ΜΑΡΑΘΩΝΟΣ, 15351 ΠΑΛΛΗΝΗ ΑΤΤΙΚΗΣ 6039336 - doxorubicin hydrochloride - inj.sol (ΕΝΕΣΙΜΟ ΔΙΑΛΥΜΑ) - 10mg/5ml vial - doxorubicin hydrochloride 2mg - doxorubicin
doxotil inj.sol 20mg/10ml vial
genepharm ae 18 ΧΛΜ. Λ. ΜΑΡΑΘΩΝΟΣ, 15351 ΠΑΛΛΗΝΗ ΑΤΤΙΚΗΣ 6039336 - doxorubicin hydrochloride - inj.sol (ΕΝΕΣΙΜΟ ΔΙΑΛΥΜΑ) - 20mg/10ml vial - doxorubicin hydrochloride 2mg - doxorubicin
doxotil inj.sol 50mg/25ml vial
genepharm ae 18 ΧΛΜ. Λ. ΜΑΡΑΘΩΝΟΣ, 15351 ΠΑΛΛΗΝΗ ΑΤΤΙΚΗΣ 6039336 - doxorubicin hydrochloride - inj.sol (ΕΝΕΣΙΜΟ ΔΙΑΛΥΜΑ) - 50mg/25ml vial - doxorubicin hydrochloride 2mg - doxorubicin
doxotil inj.sol 100mg/50ml vial
genepharm ae 18 ΧΛΜ. Λ. ΜΑΡΑΘΩΝΟΣ, 15351 ΠΑΛΛΗΝΗ ΑΤΤΙΚΗΣ 6039336 - doxorubicin hydrochloride - inj.sol (ΕΝΕΣΙΜΟ ΔΙΑΛΥΜΑ) - 100mg/50ml vial - doxorubicin hydrochloride 2mg - doxorubicin
doxorubin 10mg/vial ενεσιμο λυοφιλο
chemipharm Σ.Γ. ΝΤΕΤΣΑΒΕΣ & ΣΙΑ Ε.Ε. (0000001780) ΚΑΠΟΔΙΣΤΡΙΟΥ 42,, 104 32, ΑΘΗΝΑ, 104 32 - doxorubicin hydrochloride - ΕΝΕΣΙΜΟ ΛΥΟΦΙΛΟ - 10mg/vial - 0025316409 doxorubicin hydrochloride 10.000000 mg - doxorubicin